NCT04625361

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects

A Single Center, Randomized, Double-Blind, Placebo-Controlled Study of Single/Multiple Ascending Doses to Evaluate the Safety, Tolerability, Pharmacokinetics, and Single Center, Randomized, Double-Blind, Two Periods, Crossover, Food Effect Study of HEC122505MsOH Tablets in Healthy Chinese Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 106 (actual)
• Sponsor: Sunshine Lake Pharma Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The Safety, Tolerability, Pharmacokinetic and Food Effect Study of HEC122505MsOH Tablets in Healthy Subjects

Conditions

• Parkinson Disease

Interventions

Type	Name	Description
DRUG	HEC122505MsOH	Part2：Mulltiple doses once daily, up to 8 days

Timeline

• Start date: 2021-01-20
• Primary completion: 2022-01-06
• Completion: 2022-01-06
• First posted: 2020-11-12
• Last updated: 2023-04-13

Locations

1 site across 1 country: China